• Home
  • Industry
  • Innovation
  • Market
  • Materials
  • Products
  • Subscribe
  • Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Japan Chemical Daily

Japan's leading chemical industry newspaper

Log In

Lost your password?
Forgotten Password
Cancel
  • Home
  • Industry
  • Products
  • Materials
  • Innovation
  • Market
  • Sustainability
  • Regulatory
  • About Us
    • President’s Message
    • The Chemical Daily
  • Subscribe
    • Q & A
    • Manage my Subscription
  • 日本語
    • 化学工業日報
    • 広告掲載について

Mitsui Chemicals to Re-Enter Nucleic Acid Drug CDMO Market

Mar. 7, 2022

Filed Under: Pharma Tagged With: CDMO, Mitsui Chemicals, nucleic acid drugs

Mitsui Chemicals Inc. (TYO:4183) plans to get back involved in the CDMO business for nucleic acid drugs. By 2025, the…...

Please subscribe to read the full story.

Subscribe Free Trial

Related Articles:

NOF to Invest Big in DDS Materials in Anticipation of Growing Nucleic Acid Drug Market
NOF to Invest Big in DDS Materials in Anticipation of…
Japan Looks to Catch the West as Opportunities Open up for mRNA Pharmaceuticals
Japan Looks to Catch the West as Opportunities Open up for…
NOF Moves to Boost Production of DDS Materials for Biopharmaceuticals
NOF Moves to Boost Production of DDS Materials for…
KNC Laboratories Eyes Mass Production of Oligonucleotides for Nucleic Acid Drugs
KNC Laboratories Eyes Mass Production of Oligonucleotides…
Sumitomo Chemical Eyes Mass Production of Nucleic Acid Drug Substance for Genome Editing
Sumitomo Chemical Eyes Mass Production of Nucleic Acid Drug…
Coronavirus Report – Part 77: Japan’s Pharmaceutical Companies Move in Quick Order to Treat Infection
Coronavirus Report – Part 77: Japan’s Pharmaceutical…
Previous Post: « China’s Chemical Industry Looks to Combine Expansion With Environmental Measures
Next Post: Column: World Must Build an Energy Supply Chain Independent of Russia »

Primary Sidebar

Latest Articles

Sumco Considers Further Expansion to Deal With Demand From 2027 Onward

Jun. 30, 2022

Ube Sees Starch-Based PA Adopted in Europe

Jun. 30, 2022

Arkema Lines up Asian Boost to Production Capacity for Bio-Based PA

Jun. 30, 2022

Mitsui Chemicals Looks to Enter Sepsis Diagnostics Market

Jun. 30, 2022

AGC Aims to Expand Agrochemical CDMO Business by Developing Active Ingredients to Rival China

Jun. 30, 2022

Most Popular

  • Toray Prepares for New Era of Automotive Carbon Fiber SMC – Part 1
  • IHI Eyes Commercial Production of Methane, Olefins From CO2 Capture and Utilization
  • JG Summit Petrochemicals Finalizes $1.3B Large-Scale Expansion Investment in Batangas, Philippines
  • Showa Denko, Hitachi Chemical Proceed Toward Merging Management
  • Mitsui Chemicals Pursues Wet-Process Production of Electronic-Grade Phosphoric Acid

Tags

asahi kasei Automotive automotive materials batteries china CO2 CO2 emissions coronavirus electric vehicles environment ethylene EV health care industry trends interview investments LiB LiB materials M&A market conditions medical METI Mitsubishi Chemical Mitsubishi Chemical Holdings Mitsui Chemicals new facilities new materials petrochemical pharmaceutical polypropylene production production increase R&D recycling semiconductors Showa Denko strategy Sumitomo Chemical supply and demand Teijin thailand Toray tosoh U.S. ube industries

Footer

Log In


Lost your password?
Forgotten Password
Cancel

Links

Home
About
広告掲載について
Terms of Use
Privacy Policy
Legal Notice
Notation on the Specified Commercial Transaction Act
Contact us

© 2016–2022 The Chemical Daily Co. Ltd., Bonuterra Inc. All Rights Reserved.

japan-industry-news-network_logo

Copyright © 2022 · Chemical Daily v2 on Genesis Framework · WordPress · Log in